Literature DB >> 18596736

Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling.

B A Cardoso, L R Martins, C I Santos, L M Nadler, V A Boussiotis, A A Cardoso, J T Barata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18596736      PMCID： PMC3099237          DOI： 10.1038/leu.2008.178

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  IL-4 induces a wide-spectrum intracellular signaling cascade in CD8+ T cells.

Authors:  Ana Acacia de Sa Pinheiro; Alexandre Morrot; Sumana Chakravarty; Michael Overstreet; Jay H Bream; Pablo M Irusta; Fidel Zavala
Journal:  J Leukoc Biol       Date:  2007-01-02       Impact factor: 4.962

2.  Common gamma chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia.

Authors:  Joao T Barata; Thomas D Keenan; Ana Silva; Lee M Nadler; Vassiliki A Boussiotis; Angelo A Cardoso
Journal:  Haematologica       Date:  2004-12       Impact factor: 9.941

3.  Sequence motifs in IL-4R alpha mediating cell-cycle progression of primary lymphocytes.

Authors:  Linda M Stephenson; Do-Sim Park; Ana L Mora; Shreevrat Goenka; Mark Boothby
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

4.  Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia.

Authors:  L Karawajew; V Ruppert; C Wuchter; A Kösser; M Schrappe; B Dörken; W D Ludwig
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

5.  CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation.

Authors:  Zhang Qiuping; Xiong Jei; Jin Youxin; Ju Wei; Liu Chun; Wang Jin; Wu Qun; Liu Yan; Hu Chunsong; Yang Mingzhen; Gao Qingping; Zhang Kejian; Sun Zhimin; Li Qun; Liu Junyan; Tan Jinquan
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

6.  Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells.

Authors:  Raffaella Avellino; Simona Romano; Rosanna Parasole; Rita Bisogni; Annalisa Lamberti; Vincenzo Poggi; Salvatore Venuta; Maria Fiammetta Romano
Journal:  Blood       Date:  2005-05-05       Impact factor: 22.113

7.  Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.

Authors:  Valerie I Brown; Junjie Fang; Keith Alcorn; Rosalind Barr; Jenny M Kim; Robert Wasserman; Stephan A Grupp
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

8.  IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL.

Authors:  Joao T Barata; Vassiliki A Boussiotis; Jose A Yunes; Adolfo A Ferrando; Lisa A Moreau; J Pedro Veiga; Stephen E Sallan; A Thomas Look; Lee M Nadler; Angelo A Cardoso
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113
  8 in total
  9 in total

1.  Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity.

Authors:  Alice Melão; Maureen Spit; Bruno A Cardoso; João T Barata
Journal:  Haematologica       Date:  2016-07-28       Impact factor: 9.941

2.  Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells.

Authors:  Florencia Cayrol; María Celeste Díaz Flaqué; Tharu Fernando; Shao Ning Yang; Helena Andrea Sterle; Marcela Bolontrade; Mariana Amorós; Blanca Isse; Ricardo Norberto Farías; Haelee Ahn; Ye F Tian; Fabrizio Tabbò; Ankur Singh; Giorgio Inghirami; Leandro Cerchietti; Graciela Alicia Cremaschi
Journal:  Blood       Date:  2014-12-08       Impact factor: 22.113

3.  STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.

Authors:  Daniel Ribeiro; Alice Melão; Ruben van Boxtel; Cristina I Santos; Ana Silva; Milene C Silva; Bruno A Cardoso; Paul J Coffer; João T Barata
Journal:  Blood Adv       Date:  2018-09-11

Review 4.  Genetics of Food Allergy.

Authors:  Elisabet Johansson; Tesfaye B Mersha
Journal:  Immunol Allergy Clin North Am       Date:  2021-03-26       Impact factor: 3.479

5.  [Effect of TSC2 gene expression downregulation by lentivirus induced RNA interference on U937 cell line and its mechanism].

Authors:  Z F Xu; H X Liu; Y H Tan; X H Chen; F G Ren; Y F Zhang; J M Chang; N Zhang; J J Hu; H W Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-07-14

6.  Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia.

Authors:  Nitesh D Sharma; Christian K Nickl; Huining Kang; Wojciech Ornatowski; Roger Brown; Scott A Ness; Mignon L Loh; Charles G Mullighan; Stuart S Winter; Stephen P Hunger; Judy L Cannon; Ksenia Matlawska-Wasowska
Journal:  Cancer Sci       Date:  2019-05-03       Impact factor: 6.716

7.  Atopy manifestations in pediatric patients with acute lymphoblastic leukemia: correlation assessment with interleukin-4 (IL-4) and IgE level.

Authors:  Omid Reza Zekavat; Elham Nikpendar; Sezaneh Haghpanah; Negin Shokrgozar; Seyed Javad Dehghani; Nargess Arandi
Journal:  BMC Pediatr       Date:  2022-03-21       Impact factor: 2.125

Review 8.  Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.

Authors:  Alberto M Martelli; Francesca Chiarini; Camilla Evangelisti; Alessandra Cappellini; Francesca Buontempo; Daniela Bressanin; Milena Fini; James A McCubrey
Journal:  Oncotarget       Date:  2012-04

9.  MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways.

Authors:  X-J Li; X-Q Luo; B-W Han; F-T Duan; P-P Wei; Y-Q Chen
Journal:  Br J Cancer       Date:  2013-09-12       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.